Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...
Leopard 2 vs. Drone: How Ukraine is Adapting Germany’s Best Tank The Leopard 2 is widely considered one of the world’s best, ...
Q4 2025 Earnings Call February 19, 2026 9:00 AM ESTCompany ParticipantsKristopher Doyle - Director of Investor Relations ...
With labour unions demanding a hike in the minimum EPS-95 pension from Rs 1,000, the debate has once again reached Parliament and the Supreme Court. While the government has acknowledged ...
Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year of 2025, respectively; quarter-end cash and restricted cash position was ...
Dr. Reddy’s announces USFDA acceptance to review its Biologics License Application (BLA) for proposed interchangeable biosimilar, Abatacept.
Shares in Cytokinetics surged after it reported positive mid-stage results for CK-274, a drug for hypertrophic cardiomyopathy (HCM) that could tread on the toes of Bristol-Myers Squibb's mavacamten – ...
Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year of 2025, respectively; quarter-end cash and restricted cash position ...
Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, ...